0001104659-21-053235.txt : 20210421
0001104659-21-053235.hdr.sgml : 20210421
20210421171603
ACCESSION NUMBER: 0001104659-21-053235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210419
FILED AS OF DATE: 20210421
DATE AS OF CHANGE: 20210421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nicaise Claude
CENTRAL INDEX KEY: 0001644162
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38807
FILM NUMBER: 21842471
MAIL ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd.
CENTRAL INDEX KEY: 0001534248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
BUSINESS PHONE: 972-77-331-0156
MAIL ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
FORMER COMPANY:
FORMER CONFORMED NAME: Anchiano Therapeutics Ltd.
DATE OF NAME CHANGE: 20180906
FORMER COMPANY:
FORMER CONFORMED NAME: BioCancell Ltd.
DATE OF NAME CHANGE: 20111104
4
1
tm2113689-5_4.xml
FORM 4
X0306
4
2021-04-19
0
0001534248
Chemomab Therapeutics Ltd.
CMMB
0001644162
Nicaise Claude
319 REDSTONE DRIVE
CHESHIRE
CT
06410
1
0
0
0
Option to Purchase American Depositary Shares
27.26
2021-04-19
4
A
0
11884
0
A
2031-04-19
American Depositary Shares
11884
11884
D
These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
/s/ Matthew Rudolph, Esq., Attorney-in-Fact for Claude Nicaise
2021-04-21